54 related articles for article (PubMed ID: 16024608)
1. Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalization.
Zhou J; Pérès L; Honoré N; Nasr R; Zhu J; de Thé H
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9238-43. PubMed ID: 16757557
[TBL] [Abstract][Full Text] [Related]
2. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases.
Wu WS; Vallian S; Seto E; Yang WM; Edmondson D; Roth S; Chang KS
Mol Cell Biol; 2001 Apr; 21(7):2259-68. PubMed ID: 11259576
[TBL] [Abstract][Full Text] [Related]
3. EOR-2 is an obligate binding partner of the BTB-zinc finger protein EOR-1 in Caenorhabditis elegans.
Howell K; Arur S; Schedl T; Sundaram MV
Genetics; 2010 Apr; 184(4):899-913. PubMed ID: 20065070
[TBL] [Abstract][Full Text] [Related]
4. Sequence and structural analysis of BTB domain proteins.
Stogios PJ; Downs GS; Jauhal JJ; Nandra SK; Privé GG
Genome Biol; 2005; 6(10):R82. PubMed ID: 16207353
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor zinc finger and BTB domain 1 is essential for lymphocyte development.
Punwani D; Simon K; Choi Y; Dutra A; Gonzalez-Espinosa D; Pak E; Naradikian M; Song CH; Zhang J; Bodine DM; Puck JM
J Immunol; 2012 Aug; 189(3):1253-64. PubMed ID: 22753936
[TBL] [Abstract][Full Text] [Related]
6. Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cells.
Romanski A; Schwarz K; Keller M; Wietbrauk S; Vogel A; Roos J; Oancea C; Brill B; Krämer OH; Serve H; Ruthardt M; Bug G
Cell Cycle; 2012 Sep; 11(17):3219-26. PubMed ID: 22895185
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.
Rice KL; Hormaeche I; Doulatov S; Flatow JM; Grimwade D; Mills KI; Leiva M; Ablain J; Ambardekar C; McConnell MJ; Dick JE; Licht JD
Blood; 2009 Dec; 114(27):5499-511. PubMed ID: 19855079
[TBL] [Abstract][Full Text] [Related]
8. The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation.
Boukarabila H; Saurin AJ; Batsché E; Mossadegh N; van Lohuizen M; Otte AP; Pradel J; Muchardt C; Sieweke M; Duprez E
Genes Dev; 2009 May; 23(10):1195-206. PubMed ID: 19451220
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the BTB domain from the LRF/ZBTB7 transcriptional regulator.
Stogios PJ; Chen L; Privé GG
Protein Sci; 2007 Feb; 16(2):336-42. PubMed ID: 17189472
[TBL] [Abstract][Full Text] [Related]
10. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response.
Grignani F; Gelmetti V; Fanelli M; Rogaia D; De Matteis S; Ferrara FF; Bonci D; Grignani F; Nervi C; Pelicci PG
Oncogene; 1999 Nov; 18(46):6313-21. PubMed ID: 10597230
[TBL] [Abstract][Full Text] [Related]
11. [Acute promyelocytic leukemia, histone deacetylase, and response to retinoids].
Jeanteur P
Bull Cancer; 1998 Apr; 85(4):301-3. PubMed ID: 9752292
[TBL] [Abstract][Full Text] [Related]
12. Acute promyelocytic leukemia with a PLZF-RARalpha fusion protein.
Jansen JH; Löwenberg B
Semin Hematol; 2001 Jan; 38(1):37-41. PubMed ID: 11172538
[TBL] [Abstract][Full Text] [Related]
13. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
[TBL] [Abstract][Full Text] [Related]
14. Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein.
Li X; Peng H; Schultz DC; Lopez-Guisa JM; Rauscher FJ; Marmorstein R
Cancer Res; 1999 Oct; 59(20):5275-82. PubMed ID: 10537309
[TBL] [Abstract][Full Text] [Related]
15. Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptides.
Beez S; Demmer P; Puccetti E
PLoS One; 2012; 7(11):e48636. PubMed ID: 23152790
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
